Visceral obesity attenuates the effect of the hepatic lipase -514C > T polymorphism on plasma HDL-cholesterol levels in French-Canadian men

Molecular Genetics and Metabolism

Volumn 78, Issue 1, 2003, Pages 31-36

  St Pierre, Julie ^a,b   Miller Felix, Isabelle ^b,c   Paradis, Marie Ève ^b,c   Bergeron, Jean ^b   Lamarche, Benoît ^b,c   Després, Jean Pierre ^b,c,d   Gaudet, Daniel ^a   Vohl, Marie Claude ^b,c  

^a Dyslipidemia Diabet/A   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

French Canadians; HDL cholesterol; Hepatic lipase; SNP; Visceral obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; BIOACCUMULATION; CANADA; CONTROLLED STUDY; DETERIORATION; DNA POLYMORPHISM; FRANCE; GENETIC CODE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0346035910     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(02)00223-8     Document Type: Article

References (36)

1. Després J.P., Moorjani S., Lupien P., Tremblay A., Nadeau A., Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 10:1990;497-511.
2. Lamarche B., Deshaies Y., Moorjani S., Cantin B., Dagenais G.R., Lupien P. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. Atherosclerosis. 119:1996;235-245.
3. Lamarche B., Tchernof A., Moorjani S.et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation. 95:1997;69-75.
4. Després J.P. Clustering of risk factors for cardiovascular disease in abdominal obesity. Can. Lipidol. Rev. 1992;15-23.
5. Cohen J.C., Wang Z., Grundy S.M., Stoesz M.R., Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94:1994;2377-2384.
6. ′ flanking polymorphism in the hepatic lipase gene (LIPC) J. Lipid Res. 39:1998;228-232.
7. Jansen H., Verhoeven A.J., Weeks L.et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17:1997;2837-2842.
8. 2 cholesterol Arterioscler. Thromb. Vasc. Biol. 18:1998;1723-1729.
9. Tahvanainen E., Syvanne M., Frick M.H.et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J. Clin. Invest. 101:1998;956-960.
10. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:1997;4532-4537.
11. Jansen H., Chu G., Ehnholm C., Dallongeville J., Nicaud V., Talmud P.J. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19:1999;303-308.
12. Murtomaki S., Tahvanainen E., Antikainen M.et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler. Thromb. Vasc. Biol. 17:1997;1879-1884.
13. Standardization of anthropometric measurements, in: T. Lohman, A. Roche, R. Martorel (Eds.), The Airlie (VA) Consensus Conference, Human Kinetics Publishers, 1988, pp. 39-80.
14. Ferland M., Després J.P., Tremblay A.et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br. J. Nutr. 61:1989;139-148.
15. Desbuquois B., Aurbach G.D. Use of polyethylene glycol to separate free antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 37:1971;732-738.
16. Richterich R., Dauwalder H. Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphat-dehydrogenase-method. Schweiz. Med. Wochenschr. 101:1971;615-618.
17. Burstein M., Samaille J. Sur un dosage rapide du cholesterol lié aux alpha et aux bêta lipoprotéines du sérum. Clin. Chem. Acta. 5:1960;309.
18. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoprorteins in human serum. J. Clin. Invest. 34:1955;1345-1354.
19. Gidez L.I., Miller G.J., Burnstein M., Slagle S., Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23:1982;1206-1223.
20. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15:1966;42.
21. Moorjani S., Dupont A., Labrie F.et al. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 36:1987;244-250.
22. Després J.P., Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr. Res. Rev. 6:1993;137-159.
23. Couture P., Otvos J.D., Cupples L.A.et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 20:2000;815-822.
24. ′ flanking polymorphism in the hepatic lipase gene (LIPC) J. Lipid Res. 39:1998;228-232.
25. Dugi K.A., Brandauer K., Schmidt N.et al. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 104:2001;3057-3062.
26. Shohet R.V., Vega G.L., Anwar A., Cigarroa J.E., Grundy S.M., Cohen J.C. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler. Thromb. Vasc. Biol. 19:1999;1975-1978.
27. Botma G.J., Verhoeven A.J., Jansen H. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis. 154:2001;625-632.
28. Deeb S.S., Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J. Lipid Res. 41:2000;155-158.
29. Nie L., Wang J., Clark L.T.et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J. Lipid Res. 39:1998;1127-1130.
30. Després J.P., Ferland M., Moorjani S.et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 9:1989;485-492.
31. Juo S.H., Han Z., Smith J.D., Colangelo L., Liu K. Promoter polymorphisms of hepatic lipase gene influence HDL (2) but not HDL (3) in African American men: CARDIA study. J. Lipid Res. 42:2001;258-264.
32. Pihlajamaki J., Karjalainen L., Karhapaa P.et al. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 20:2000;1789-1795.
33. Hegele R.A., Harris S.B., Brunt J.H.et al. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis. 146:1999;153-160.
34. Carr M.C., Hokanson J.E., Deeb S.S., Purnell J.Q., Mitchell E.S., Brunzell J.D. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler. Thromb. Vasc. Biol. 19:1999;2701-2707.
35. Talmud P.J., Berglund L., Hawe E.M.et al. Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics. 108:2001;E50.
36. Tan K.C., Shiu S.W., Chu B.Y. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis. 157:2001;233-239.